The Synergist

The Synergist brings together diverse stakeholders—including patients, industry leaders, hospitals, universities, and foundations—to co-create solutions addressing complex societal challenges in healthcare. Its flagship initiatives include improving access to precision medicine ("FT3"), advancing patient-focused medicines development ("PFMD"), catalyzing global patient movements ("PMC"), supporting maternal health outcomes ("MCIP"), promoting liquid biopsy adoption for cancer monitoring ("Guide.MRD"), and empowering patients with actionable health information (“Gravitate Health”). The organization manages fundraising, communications, technical development, strategic direction-setting for these collaborations. It does not develop drugs or devices itself but enables innovation ecosystems that do.